Call for Abstract

2nd World Congress on Epilepsy and Brain Disorders, will be organized around the theme “Elimination of Epilepsy & New Innovations in Brain Disorders”

Epilepsy Congress 2020 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Epilepsy Congress 2020

Submit your abstract to any of the mentioned tracks.

Register now for the conference by choosing an appropriate package suitable to you.

  • Track 1-1Synchronous neuronal activity
  • Track 1-2Fibromyalgia
  • Track 1-3Yoga & meditation
  • Track 1-4Cavernous hemangioma
  • Track 1-5Hepatic encephalopathy
  • Track 1-6Hypoxic ischemic encephalopathy
  • Track 1-7Psychosis
  • Track 1-8Automatisms
  • Track 1-9Jacksonian march or Focal seizures
  • Track 1-10Brain infection
  • Track 1-11Migraine and other headache disorders
  • Track 2-1Multiple sclerosis
  • Track 2-2Arthritis, especially osteoarthritis
  • Track 2-3Cluster headaches
  • Track 2-4Shingle
  • Track 2-5Diabetic neuropathy
  • Track 2-6Nerve damage
  • Track 2-7Carpal tunnel syndrome
  • Track 3-1Neuropsychiatry
  • Track 3-2Alzheimer disease
  • Track 3-3Cerebrovascular diseases including stroke
  • Track 3-4Neuroinfections
  • Track 3-5Brain Tumours
  • Track 3-6Neurological Disorders as a result of Malnutrition
  • Track 3-7Neuromuscular transmission disorders
  • Track 4-1Neurogenetics
  • Track 4-2Neuroradiology
  • Track 4-3Autism Spectrum Disorder
  • Track 4-4Behavioral neurology
  • Track 4-5Neuropathology
  • Track 4-6Schizophrenia
  • Track 4-7Cognitive psychology
  • Track 4-8Neuroanatomy
  • Track 4-9Parallel processing
  • Track 4-10Parallel processing
  • Track 4-11Meningitis
  • Track 5-1Brain injury
  • Track 5-2Neurostimulation
  • Track 5-3Convulsive
  • Track 5-4Psychogenic non-epileptic seizures
  • Track 5-5Obsessive–compulsive disorder
  • Track 5-6 Attention deficit hyperactivity disorder
  • Track 5-7Infections of the central nervous system
  • Track 5-8Neurocysticercosis
  • Track 6-1Psychometric tests
  • Track 6-2Psychotherapy
  • Track 6-3Psychiatric medication
  • Track 6-4Dementia
  • Track 6-5Deviant behavior
  • Track 6-6Psychodynamic Diagnostic
  • Track 6-7Addictive behaviors
  • Track 6-8Hallucinations
  • Track 6-9Drug or alcohol abuse
  • Track 7-1Clinical psychology
  • Track 7-2Rehabilitation
  • Track 7-3Psychotic disorders
  • Track 7-4 Depressive disorders
  • Track 7-5Anxiety disorders
  • Track 7-6Hyperactivity disorder
  • Track 7-7Post traumatic stress disorder
  • Track 7-8Metacognitive therapy
  • Track 8-1Dysthymia
  • Track 8-2Bereavement
  • Track 8-3Peer pressure
  • Track 8-4Neuroticism
  • Track 8-5Antimigraine drugs
  • Track 9-1Drinkaware
  • Track 9-2Status epilepticus
  • Track 9-3Anti-epileptic drugs (AEDs)
  • Track 9-4Blood levels
  • Track 10-1Refractory epilepsy
  • Track 10-2Atonic seizures
  • Track 10-3Myoclonic seizures
  • Track 11-1Catamenial Seizures
  • Track 11-2Labour and Delivery
  • Track 11-3Inherited epilepsy
  • Track 11-4Anticonvulsant medication
  • Track 11-5Breastfeeding
  • Track 11-6Anti-Epileptic Drugs and the Developing Fetus
  • Track 11-7Sodium valproate and Valproic acid
  • Track 12-1Antiepileptic drugs (AEDs)
  • Track 12-2Electronic Medicines Compendium
  • Track 12-3Monotherapy
  • Track 12-4Add-on therapy
  • Track 12-5Idiopathic epilepsy
  • Track 12-6Nerve pain medication
  • Track 12-7Sedative
  • Track 12-8Anticonvulsant
  • Track 12-9Oxcarbazepine
  • Track 13-1Brain disorders
  • Track 13-2Encephalitis
  • Track 13-3Memory problems
  • Track 13-4Sleep disorders
  • Track 13-5Stroke
  • Track 13-6Brain surgery, coma
  • Track 13-7Electrode
  • Track 13-8Hemorrhage
  • Track 13-9Migraines
  • Track 13-10Neuroimaging
  • Track 14-1Long-term video-EEG monitoring
  • Track 14-2Ketogenic diet
  • Track 14-3Callosotomy
  • Track 14-4Brain mapping
  • Track 14-5Magnetoencephalography (MEG)
  • Track 14-6Intracarotid sodium amobarbital test (Wada test)
  • Track 14-7Positron emission tomography (PET)
  • Track 14-8Single photon emission computed tomography (SPECT)
  • Track 14-9MRI
  • Track 14-10Neuropsychological evaluation
  • Track 14-11Acupuncture
  • Track 15-1Hydrocotyle
  • Track 15-2Melatonin and epilepsy
  • Track 15-3Cerebral folate deficiency
  • Track 15-4Chiropractic treatments
  • Track 16-1Fueling brain function
  • Track 16-2Atkins diet
  • Track 16-3Medium-chain triglycerides
  • Track 16-4Amyotrophic lateral sclerosis (ALS)
  • Track 16-5Brain cancer
  • Track 16-6Neurotrauma
  • Track 16-7Hypersynchronous